Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies

计划入组 40 人 · 首次发布于 2018 年 9 月 17 日

Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors

计划入组 55 人 · 首次发布于 2023 年 9 月 11 日

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

计划入组 102 人 · 首次发布于 2025 年 10 月 9 日

dual immune checkpoint blockers

checkpoint inhibitors (Immune Design)

immune checkpoint targeting mAb

BCN Checkpoint

Checkpoint Therapeutics

United States

ImmunoBrain Checkpoint Ltd.

Israel

Chromophobe Renal Cell Carcinoma Shows Immune-Cold Environment and Poor Response to Checkpoint Inhibitors

Immune Checkpoint Inhibitors Show Superior Durable Responses Compared to Other Systemic Therapies

Mayo Clinic Develops Novel Approach to Enhance Cancer Immunotherapy by Targeting Myeloid Cells